Add like
Add dislike
Add to saved papers

Image-based QSAR model for prediction of P-gp inhibitory activity of epigallocatechin and gallocatechin derivatives.

BACKGROUND: Permeability glycoprotein (P-gp) is one of the cell membrane proteins that can pushed some drugs out of the cell and it causes drug tolerance and its inhibition can prevent drug resistant.

OBJECTIVE: In this study, we used image-based quantitative structure-activity relationship (QSAR) models to predict the P-gp inhibitory activity of epigallocatechin and gallocatechin derivatives.

METHODS: The 2D-chemical structures and their P-gp inhibitory activity were taken from literature. The pixels of images and their principal components (PCs) were calculated using MATLAB software. Principle component regression (PCR), artificial neural network (ANN) and support vector machine (SVM) approaches were used to develop QSAR models. Statistical parameters included the leave one out cross-validated correlation coefficient (q2) for internal validation of the models and R2 of test set, root mean square error (RMSE) and concordance correlation coefficient (CCC) were applied for external validation.

RESULTS: Six PCs from image analysis method were selected by stepwise regression for developing linear and non-linear models. Non-linear models i.e. ANN (with the R2 of 0.80 for test set) were chosen as the best for the established QSAR models.

CONCLUSION: According to the result of the external validation, ANN model based on image analysis method can predict the P-gp inhibitory activity of epigallocatechin and gallocatechin derivatives better than the PCR and SVM models.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app